This post is the first in a five-part series summarizing APDA’s recent “Ask the Expert” event on Smart Patients. During the ...
Better understanding of Parkinson’s removes the mystery. Here are five points to provide clarity, prompt action and give hope ...
"Among the aims of the research team is to better understand whether gene therapy may one day provide a different approach to ...
Deep brain stimulation of the subthalamic nucleus has long been one of the most dramatic interventions in neurology: ...
Freezing of Gait (FOG) is a disabling feature of Parkinson’s disease (PD). However, the neural mechanisms underlying voluntary stopping impairments remain unclear. This study used a validated Virtual ...
Research conducted by the Fraunhofer Institute for Integrated Circuits (IIS) in Germany and others has revealed that the ...
JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...
For people with muscular dystrophy, who may experience problems with muscle strength, endurance, balance, joint stiffness, ...
Betsy Salquist Will Provide Specialized Speech and Swallowing Therapy for Patients Living With Parkinson’s Disease.
A hospital in Japan has carried out the world's first surgery using sheets of commercially available heart muscle stem cells ...
A hospital in Japan has carried out the world's first surgery using sheets of commercially available heart muscle stem cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results